Ping An Biomedical Balance Sheet

Financials in millions CNY. Fiscal year is October - September.

Millions CNY. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	36.7	0.13	0.59	1.17	0.11
Cash & Short-Term Investments	36.7	0.13	0.59	1.17	0.11
Cash Growth	27928.92%	-77.88%	-49.26%	1003.53%	-33.40%
Accounts Receivable	16.93	40.44	47.09	57	49.02
Other Receivables	9.63	12.61	25.7	16.25	5.23
Total Trade Receivables	26.56	53.05	72.79	73.25	54.24
Inventory	0.44	0.13	3.19	4.63	16.02
Total Current Assets	63.7	53.31	76.57	79.04	70.36
Net Property, Plant & Equipment	0.47	0.82	0.54	0.18	0.57
Other Long-Term Assets	4.25	2.72	2.73	2.72	2.77
Total Assets	68.41	56.85	79.84	81.95	73.71
Accounts Payable	9.41	15.06	9.27	18.04	7.14
Accrued Expenses	0.29	0.61	0.86	1.79	0.29
Short-Term Debt	10	10	42.5	35.5	28.5
Current Portion of Leases	0.37	0.35	0.39	0.07	0.39
Unearned Revenue	0.07	1.67	0.53	0.27	1.67
Other Current Liabilities	2.93	35.89	32.08	21.68	37.72
Total Current Liabilities	23.08	63.58	85.63	77.35	75.7
Long-Term Leases	0.1	0.46	0.07	-	0.07
Total Long-Term Liabilities	0.1	0.46	0.07	-	0.07
Total Liabilities	23.17	64.04	85.7	77.35	75.77
Common Stock	0.01	0.01	0.01	0.01	0
Additional Paid-in Capital	66.21	-	-	-	0
Accumulated Other Comprehensive Income	-1.61	-0.66	-0.93	-1.07	-0.49
Retained Earnings	-19.37	-6.54	-4.94	5.66	-1.57
Shareholders' Equity	45.24	-7.19	-5.86	4.6	-2.06
Total Liabilities & Equity	68.41	56.85	79.84	81.95	73.71
Total Debt	10.47	10.81	42.96	35.57	28.96
Net Cash (Debt)	26.23	-10.68	-42.36	-34.4	-28.85
Net Cash Per Share	1.42	-0.59	-2.35	-1.91	-1.60
Book Value	45.24	-7.19	-5.86	4.6	-2.06
Book Value Per Share	2.45	-0.40	-0.33	0.26	-0.11
Tangible Book Value	45.24	-7.19	-5.86	4.6	-2.06
Tangible Book Value Per Share	2.45	-0.40	-0.33	0.26	-0.11